e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Diffuse parenchymal lung disease II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Secondary pulmonary alveolar proteinosis associated with IgG4-related disease
J. Kojima, H. Hara, T. Numata, K. Shimizu, M. Kawaishi, K. Saito, J. Araya, Y. Kaneko, K. Nakayama, K. Kuwano (Tokyo, Japan)
Source:
Annual Congress 2013 –Diffuse parenchymal lung disease II
Session:
Diffuse parenchymal lung disease II
Session type:
Thematic Poster Session
Number:
2371
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Kojima, H. Hara, T. Numata, K. Shimizu, M. Kawaishi, K. Saito, J. Araya, Y. Kaneko, K. Nakayama, K. Kuwano (Tokyo, Japan). Secondary pulmonary alveolar proteinosis associated with IgG4-related disease. Eur Respir J 2013; 42: Suppl. 57, 2371
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Imaging of complicated pneumonia: what is new?
Related content which might interest you:
Indication of whole lung lavage in pulmonary alveolar proteinosis – Retrospective study
Source: International Congress 2015 – IIPs: orphan
Year: 2015
Bronchoalveolar lavage in idiopathic pulmonary fibrosis
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017
Bronchoalveolar lavage
Source: Eur Respir Mon; 2010: 48: 59–72
Year: 2010
Multiple segmental lavage in the treatment of pulmonary alveolar proteinosis
Source: International Congress 2014 – ILDs 6
Year: 2014
Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis
Source: Eur Respir J 2004; 23: 526-531
Year: 2004
Cytofluorimetric BAL cells characterization in IPF and in other ILD
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
Clinical significance of hemosiderin-laden macrophages in bronchoalveolar lavage fluid of patients with idiopathic interstitial pneumonias
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Bronchoalveolar lavage findings in patients with diffuse interstitial lung disease (DILDs)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Pulmonary alveolar proteinosis and long-term outcome after bronchopulmonary lavage
Source: International Congress 2017 – Paediatric bronchology
Year: 2017
Usefulness of bronchoalveolar lavage in the diagnosis of desquamative interstitial pneumonia
Source: International Congress 2014 – ILDs 2
Year: 2014
Efficacy of total lung lavage in pulmonary alveolar proteinosis: A multicenter international study of GELF
Source: International Congress 2016 – Advancements in bronchoscopy
Year: 2016
Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful?
Source: Eur Respir J 2011; 38: 761-769
Year: 2011
KL-6 in whole lung lavage fluid of patients with pulmonary alveolar proteinosis
Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease
Year: 2009
Autophagy is not impaired in BALF alveolar macrophages in IPF: Preliminary results
Source: International Congress 2014 – ILDs 3
Year: 2014
Determinants of protein concentration in whole lung lavage of patients with pulmonary alveolar proteinosis
Source: Annual Congress 2009 - From genetics to clinics in diffuse parenchymal lung diseases
Year: 2009
The benefits of whole lung lavage in pulmonary alveolar proteinosis
Source: Eur Respir J 2004; 23: 503-505
Year: 2004
Idiopathic pulmonary alveolar proteinosis: GM CSF therapy and whole lung lavage a case report
Source: Eur Respir J 2003; 22: Suppl. 45, 44s
Year: 2003
Calgranuline B in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009
Cytokine profile in bronchoalveolar lavage fluid of fibrotic idiopathic intersticial pneumonias compared to fibrotic intersticial pneumonias in connective tissue diseases
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
The clinical utility of bronchoalveolar lavage in diffuse parenchymal lung disease
Source: Eur Respir Rev 2010 19: 237-241
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept